ACTH (Cosyntropin)

Cosyntropin is a synthetic analog of the first 24 amino acids of adrenocorticotropic hormone (ACTH 1-24). It is FDA-approved as a diagnostic agent for adrenal insufficiency testing (Cortrosyn). Also used therapeutically in certain conditions such as infantile spasms.

At a Glance

Summary: Binds MC2R receptors on adrenal cortex cells to stimulate cortisol and corticosteroid synthesis, used diagnostically to assess adrenal reserve and therapeutically for specific conditions. Mechanisms (reported/proposed across domains): Adrenal stimulation • Binds melanocortin 2 receptor (MC2R) on zona fasciculata cells of the adrenal cortex, activating adenylyl cyclase and...

Safety Profile

FDA Approved (Diagnostic)

Research Dosing

Dose: 250 mcg (standard) or 1 mcg (low-dose test) · Route: Intravenous (IV) · Intramuscular (IM) · Frequency: Single dose (diagnostic) or per protocol (therapeutic) · Duration: Single use (diagnostic)

Categories

  • FDA Approved
  • Diagnostic Tool
  • Melanocortin
  • Clinical Data Available
  • As-Needed Dosing

Related Peptides

The Leading Community for Trusted Peptide Research & Insights

Research summaries, dosing protocols, and community reports for peptides. Built on clinical data and real-world experiences.